Nick Plummer
General Counsel chez VOLITIONRX LIMITED
Profil
Nick Plummer is currently the Group General Counsel at VolitionRX Ltd.
Prior to this, he worked as the Managing Counsel-Europe at Patheon France SAS from 2013 to 2021.
He also worked as the Secretary & General Counsel at Ark Therapeutics Group Plc from 2004 to 2008 and at Novacyt SAS as the Secretary & General Counsel.
Additionally, he worked at Ashurst Morris Crisp from 2004 to 2007.
Postes actifs de Nick Plummer
Sociétés | Poste | Début |
---|---|---|
VOLITIONRX LIMITED | General Counsel | 01/11/2021 |
Anciens postes connus de Nick Plummer
Sociétés | Poste | Fin |
---|---|---|
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Patheon France SAS provides drug development and manufacturing services. The company is headquartered in Bourgoin-Jallieu, France. | Corporate Officer/Principal | 01/01/2021 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | General Counsel | 01/01/2008 |
NOVACYT | General Counsel | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
NOVACYT | Health Technology |
VOLITIONRX LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Patheon France SAS
Patheon France SAS Pharmaceuticals: MajorHealth Technology Patheon France SAS provides drug development and manufacturing services. The company is headquartered in Bourgoin-Jallieu, France. | Health Technology |